You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

umeclidinium bromide

Showing 1 - 25 of 304
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Sep 7, 2022

Using US Medical and Pharmacy Claim Records to Compare Resource

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • Eden Prairie, Minnesota
    Optum
Mar 11, 2022

COPD, Non Small Cell Lung Cancer Trial in Seoul (Vilanterol and Umeclidinium Bromide, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Non Small Cell Lung Cancer
  • Vilanterol and Umeclidinium Bromide
  • Placebo
  • Seoul, Korea, Republic of
    Samsung Medical Center
Apr 1, 2021

Based on Medical Records That Looks at Duration of Use of Two

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Olodaterol/Tiotropium Bromide
  • Umeclidinium/ Vilanterol
  • New York, New York
    Aetion Inc.
Nov 12, 2021

Asthma Trial in Japan (FF/UMEC/VI 100/62.5/25 mcg, FF/UMEC/VI 200/62.5/25 mcg, Salbutamol)

Completed
Has Results
  • Asthma
  • FF/UMEC/VI 100/62.5/25 mcg
  • +3 more
  • Gifu, Japan
  • +12 more
May 14, 2020

Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
  • Fluticasone furoate/umeclidinium/vilanterol
  • Waterbury, Connecticut
  • +2 more
Apr 21, 2020

Asthma, COPD Trial in Manchester (CHF6366, Placebo CHF6366, umeclidinium bromide and vilanterol trifenatate)

Completed
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Manchester, United Kingdom
    Medicines Evaluation Unit
May 5, 2020

Pulmonary Disease, Chronic Obstructive Trial in China, Korea, Republic of (Umeclidinium bromide, Placebo)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Umeclidinium bromide
  • Placebo
  • Guangzhou, Guangdong, China
  • +25 more
Jun 12, 2020

Study to Evaluate the Risk of Cardiovascular Endpoints

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Aclidinium bromide
  • Other COPD medication
  • London, United Kingdom
    Clinical Practice Research Datalink
Jan 30, 2023

Asthma Trial in Worldwide (Placebo, UMEC, Fluticasone Furoate)

Completed
Has Results
  • Asthma
  • Placebo
  • +3 more
  • Tempe, Arizona
  • +69 more
Oct 6, 2020

Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)

Terminated
  • Pulmonary Disease, Chronic Obstructive
  • Bronchodilator Agents
  • Bari, BA, Italy
  • +38 more
Dec 23, 2022

US Based on Pharmacy and Medical Claims That Compares How Well

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • White Plains, New York
    eMax health
Jan 11, 2022

Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Andalusia, Alabama
  • +71 more
Jul 13, 2021

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/UMEC/VI, Inhaled Corticosteroid, LAMA)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Aschaffenburg, Bayern, Germany
  • +142 more
Aug 19, 2020

COPD Trial in India, United States (Test Product - Tiotropium Bromide Inhalation Powder 18 mcg, Spiriva Handihaler (Tiotropium

Active, not recruiting
  • COPD
  • Test Product - Tiotropium Bromide Inhalation Powder 18 mcg
  • +2 more
  • Los Angeles, California
  • +32 more
Aug 3, 2023

Asthma Trial (FF/UMEC/VI, ELLIPTA, FF/VI)

Not yet recruiting
  • Asthma
  • (no location specified)
Feb 24, 2023

Succinylcholine, Myofibrillation Trial in Yangzhou (rocuronium)

Enrolling by invitation
  • Succinylcholine
  • Myofibrillation
  • Yangzhou, Jiangsu, China
    the Affiliated Hospital of Yangzhou University, Yangzhou Univers
Jun 10, 2023

COPD Trial in Guangzhou (Tiotropium Bromide Combined With Odaterol)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Tiotropium Bromide Combined With Odaterol
  • Guangzhou, Guangdong, China
    Guangzhou Institute of Respiratory Diseases
Oct 19, 2022

Primary Axillary Hyperhidrosis Trial in Rogers (Sofpironium Bromide Gel, 15%)

Completed
  • Primary Axillary Hyperhidrosis
  • Sofpironium Bromide Gel, 15%
  • Rogers, Arkansas
    Northwest Arkansas Clinical Trials Center
Dec 19, 2022

Axillary Hyperhidrosis Trial in United States (Sofpironium Bromide, 15%, Vehicle)

Completed
  • Axillary Hyperhidrosis
  • Birmingham, Alabama
  • +41 more
Dec 23, 2022

COPD Trial in Worldwide (Aclidinium bromide/formoterol Fixed-Dose Combination, Aclidinium bromide, Formoterol Fumarate)

Completed
  • COPD
  • Aclidinium bromide/formoterol Fixed-Dose Combination
  • +3 more
  • Anhui, China
  • +74 more
May 23, 2022

Asthma Trial (QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149)

Not yet recruiting
  • Asthma
  • (no location specified)
Mar 18, 2023

Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)

Recruiting
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Gold River, California
  • +56 more
Oct 7, 2020

Pulmonary Disease, Chronic Obstructive Trial in Czechia, Germany, United States (budesonide/formoterol, albuterol/salbutamol,

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Mobile, Alabama
  • +56 more
Oct 7, 2020